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SUMMARY 
Objectives: To determine the epidemiology and recur-
rence rate of pterygium after excision using bare sclera 
technique 
Design: Prospective non-comparative study.  
Setting: Ophthalmology unit, Korle-Bu Teaching Hos-
pital, Accra, Ghana. 
Methods: The study involved 60 consecutive patients 
with primary apterygial from July 1998 to December 
2000 who had bare sclera excision after informed con-
sent. They were post-operatively followed up for 30-
months. 
Results: Thirty-five patients (58%) were females. The 
patients' ages ranged from 17-75 years, mean (±12.6). 
Overall recurrence was 22(37%). The main complica-
tions encountered include were granuloma 20 %( 
n=12), restriction in medial rectus muscle motility 
2(3%), persistent vascularisation at excision site 2(3%) 
and adherence leucoma with uveitis 1(2%). No signifi-
cant association was found between recurrence and 
pterygium morphology, calcification, allergy and occu-
pation (indoor or outdoor).  
Conclusion: The recurrence rate after pterygium exci-
sion using bare sclera technique in Ghanaians is high 
(37%).  
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INTRODUCTION 
Pterygium is a benign fibrovascular growth which in-
vades the cornea from the conjunctiva and is common 
in the tropics. It is associated with ultraviolet light and 
also dusty environment. [1, 2] It often gives rise to irrita-
tion, redness and eye discomfort and is cosmetically 
unsightly.  Treatment is surgical but high recurrence 
rates are primarily seen after bare sclera surgery, 24-
>80%, [3, 4, 5, 6] and remains a problem. Different adju-
vants to bare sclera surgery have been tried all aiming 
at reducing the recurrence. These include B-radiation 
with Strontium-90, chemotherapeutic agents such as 
mitomycin-C and conjunctival autograft. 7-10 
 
At the time of this study, the surgical procedure com-
monly performed was excision using bare sclera tech-
nique. Anecdotal observation has shown both successes 
and recurrences after long-term follow up in years.  
Over the years, some ophthalmologists have modified 
their practice with a gradual shift towards the use of 
adjuvants to bare sclera surgery such as mitomycin-C 
and conjunctival autograft.  
 
There are still some ophthalmologists who perform 
bare sclera excision alone in Ghana. The study there-
fore aimed at determining the epidemiology of primary 
pterygium and recurrence rate after excision using bare 
sclera technique in Ghanaians. 
 
METHODS 
Sixty consecutive patients with primary pterygia who 
had bare sclera excision after informed consent at the 
Ophthalmology unit, Korle-Bu Teaching Hospital, 
Ghana, from July 1998 to December 2000 were stud-
ied. They were post-operatively followed up for 30-
months. 
 
A structured questionnaire was used to collect infor-
mation on the patients’ occupation (outdoor or indoor), 
use of spectacles, history of allergy or atopy, and any 
other ocular disease. In addition, clinical examination 
noted the morphology of the pterygia 
(fleshy/vascularised, intermediate, or atrophic) based 
on the translucency of the pterygia and presence or 
absence of calcification, its laterality (unilateral or bi-
lateral), location (nasal, temporal or kissing), its extent 
into cornea and encroachment on the visual axis.  
 
Data analysis  
Time of recurrence in months was summarized as 
means and standard deviation. Chi-square test was used 
to compare the proportions of various categories of 
 
 




conditions. Logistic regression was employed to estab-
lish causal associations between various risk factors. 




Demographics: Thirty-five patients (58%) were fe-
males. The patients' ages ranged from 17-75 years, 
mean (±12.6).  
Laterality:  37(62%) were bilateral; 13(21.7%) were 
left and 10 (16.7%) were right. 
Orientation: 57(95.0%) were nasal; 1(1.7%) temporal 
and 2 (3.3%) kissing (both nasal and temporal in the 
affected eye).   
Calcification: 20 out of 60(33%) demonstrated pres-
ence of calcifications.  
Morphology:  7(12%) were transparent/ atrophic (T1); 
41(68%) were intermediate (T2) and 12(20%) were 
vascularised / fleshy (T3). 
Allergy: Nineteen out of sixty (32%) admitted to hav-
ing allergy to dust, 17/60(28%) to perfume and 
11(18%) to history of asthma. 
Recurrence:  The overall recurrence was 22(37%). 
The mean time of recurrence was 4.27(±2.03) months. 
The recurrence time showed a bimodal pattern at 
3months: 10(45%) and at 6 months: 7(32%).  
Complications: The main complications encountered 
were granuloma 20 %( n=12), restriction in medial 
rectus muscle motility 2(3%), persistent vascularisation 
at excision site 2(3%) and adherence leucoma with 
uveitis 1(2%). No significant association was found 
between recurrence and pterygium morphology, pres-




This study provides basic epidemiological and clinical 
features of pterygium, a common eye disease in warm 
climates. The overall recurrence was high, 37%.  This 
high recurrence rate corroborates other findings associ-
ated with bare-sclera technique alone as a method of 
treatment of pterygium, compared with other forms of 
surgical or adjuvant treatments.5, 8-16   
 
The risk factors for recurrence include geographic loca-
tion17, age15, morphology and fleshiness or vascularity 
of pterygium15 and other factors such as allergy or im-
munological factors.18-20 This study did not demon-
strate any significant association between recurrence 
and vascularity (atrophic, vascularised), allergy to dust, 
allergy to perfumes and spray, history of asthma, or 
type of occupation (indoor or outdoor) and gender.  
 
Majority of the recurrences were observed in the first 
year post excision with a bimodal presentation with 
peaks at 3 and 6 months. This pattern of recurrence is 
corroborated by Hirst et al who also found a 97% 
chance of recurrence within 12 months of the removal 
without the bimodal component.21  
The bimodal pattern of recurrence observed was unex-
pected. This finding has not been highlighted in the 
literature.  
 
Table 1 Relationship between recurrence and risk fac-
tors for pterygium. 
 
Further studies in the Ghanaian population using larger 
series are needed to establish whether this pattern of 
recurrence was an incidental finding or something pe-
culiar to our population. There was no gender differ-
ence with respect to pterygium occurrence; male: fe-
male ratio was 5:7. In the literature, there had been 
conflicting reports on the male to female ratio in pa-
tients with pterygium. Whereas some report male pre-
ponderance as in Southern India11,20,21  others show 
female preponderance as in Ibadan in Nigeria where 
the male: female ratio was found to be 5:6.5   
 
However, the difference in this study was not statisti-
cally significant. The difference is sometimes thought 
to be due to more exposure to environmental factors in 
the males as a result of their mostly outdoor occupa-
tion. Places where the females work outdoors as fre-
quently as their male counterparts, as may be found in 
urban areas in Africa like Ibadan and Accra,5 there may 
be no gender difference or even a female preponder-
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ance. The latter may also be due to females being more 
cosmetically conscious of the growth.  
 
 
The age range affected was 17-75 years with a mean 
age of 45.6 years. This compares with other studies on 
prevalence of pterygium where it occurs about the se-
cond decade with the highest prevalence in the 4th and 
5th decades.5,14, 22,23 A few occurrences have been seen 
in the 1st decade though. 14,24 
 
The commonest presentation was bilateral in 61.7%. 
This supports findings from the West African sub-
region where Ashaye found 71% of his patients to have 
bilateral presentation, 5 but this contradicts the findings 
from India where Fernandes M. et al found only 7.5% 
of the patients to have bilateral pterygia.14 Ibechukwu 
in Jos, Nigeria, found the occurrence of pterygium on 
the right side to be commoner than the left with a ratio 
of 1.3:1 13 a finding also observed by Hirst et. al.21 
 
The lesion was found on the nasal side predominantly 
(95%) and hardly on the temporal side (2%) or both 
nasal and temporal (kissing or double pterygia) (3%). 
This corroborates findings from other studies.5, 13It is 
not clear the reason for this occurrence.  
 
Calcifications were found in a third of the lesions and 
most were vascularised i.e. intermediate and fleshy 
(88%). Very few atrophic ones were seen (12%) as 
reported in other studies.5,14,16 
 
Only 32% of our study population had a history of al-
lergy (to dust, perfumes, sprays and drugs). The preva-
lence of allergy in Ghana is unknown. No significant 
association was found between allergy or asthma and 
pterygium recurrence. This observation may be due to 
the small numbers that reported a history of allergy, 
atopy or asthma, which could also be attributed to the 
difficulty encountered in obtaining such history from 
this population.25 
 
Granulomas are recognised minor post-operative com-
plications seen with bare sclera technique, and other 
serious complications such as medial rectus restriction 
are also known complications.16 
 
CONCLUSION 
The recurrence rate after pterygium excision using bare 
sclera technique in Ghanaians is high (37%). This 
study is the first to determine the recurrence rate of 
pterygium excision with bare sclera technique in Gha-
naians and provides important and relevant information 
for ophthalmic practice in Ghana. This finding should 
discourage the use of this technique alone by ophthal-
mic surgeons in Ghana as in other parts of the world. 
The finding would also form the basis for comparison 
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